Tag: cancer drug approval
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment
AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...